Open access · US-GOV via ClinicalTrials.gov Clinical trial

Effects of NAD3 Supplementation on Biomarkers of Anti-Aging in Healthy Men and Women

Authors not listed

The Center for Applied Health Sciences, LLC · 2020

Dysbiosis Human Randomized controlled trial

Abstract

This is a randomized, parallel-group, placebo-controlled, clinical trial in middle-aged and older male and female subjects from Ohio. Subjects will take an over-the-counter dietary supplement or a placebo for 12 weeks. Outcome measures will include body weight, systolic and diastolic blood pressure, standard blood chemistries (e.g. chemistry panel, lipid panel, CBC with differential), changes in mood, vitality, energy, fatigue, productivity, digestive wellness (via anchored Visual Analogue Scales).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-05-31 MST

Cite this

APA

Anonymous. (2020). Effects of NAD3 Supplementation on Biomarkers of Anti-Aging in Healthy Men and Women. <em>The Center for Applied Health Sciences, LLC</em>. https://clinicaltrials.gov/study/NCT04276948

Vancouver

Anonymous. Effects of NAD3 Supplementation on Biomarkers of Anti-Aging in Healthy Men and Women. The Center for Applied Health Sciences, LLC. 2020.

BibTeX

@misc{anon2020Effect, title = {Effects of NAD3 Supplementation on Biomarkers of Anti-Aging in Healthy Men and Women}, author = {Anonymous}, journal = {The Center for Applied Health Sciences, LLC}, year = {2020}, }